Most of patients with localized prostate cancer will be treated in the future? | Opinion: No.
Publication
, Journal Article
Schulman, AA; Polascik, TJ
Published in: Int Braz J Urol
2017
Duke Scholars
Published In
Int Braz J Urol
DOI
EISSN
1677-6119
Publication Date
2017
Volume
43
Issue
4
Start / End Page
584 / 587
Location
Brazil
Related Subject Headings
- Urology & Nephrology
- Risk Assessment
- Prostatic Neoplasms
- Prostate-Specific Antigen
- Prognosis
- Male
- Magnetic Resonance Imaging
- Humans
- Forecasting
- Early Detection of Cancer
Citation
APA
Chicago
ICMJE
MLA
NLM
Schulman, A. A., & Polascik, T. J. (2017). Most of patients with localized prostate cancer will be treated in the future? | Opinion: No. Int Braz J Urol, 43(4), 584–587. https://doi.org/10.1590/S1677-5538.IBJU.2017.04.03
Schulman, Ariel A., and Thomas J. Polascik. “Most of patients with localized prostate cancer will be treated in the future? | Opinion: No.” Int Braz J Urol 43, no. 4 (2017): 584–87. https://doi.org/10.1590/S1677-5538.IBJU.2017.04.03.
Schulman AA, Polascik TJ. Most of patients with localized prostate cancer will be treated in the future? | Opinion: No. Int Braz J Urol. 2017;43(4):584–7.
Schulman, Ariel A., and Thomas J. Polascik. “Most of patients with localized prostate cancer will be treated in the future? | Opinion: No.” Int Braz J Urol, vol. 43, no. 4, 2017, pp. 584–87. Pubmed, doi:10.1590/S1677-5538.IBJU.2017.04.03.
Schulman AA, Polascik TJ. Most of patients with localized prostate cancer will be treated in the future? | Opinion: No. Int Braz J Urol. 2017;43(4):584–587.
Published In
Int Braz J Urol
DOI
EISSN
1677-6119
Publication Date
2017
Volume
43
Issue
4
Start / End Page
584 / 587
Location
Brazil
Related Subject Headings
- Urology & Nephrology
- Risk Assessment
- Prostatic Neoplasms
- Prostate-Specific Antigen
- Prognosis
- Male
- Magnetic Resonance Imaging
- Humans
- Forecasting
- Early Detection of Cancer